Saphenous Vein Graft Disease
📧 Sign up to get email alerts when something new happens for Saphenous Vein Graft Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis [Phase 4]
Phase 4 clinical trial evaluating ticagrelor to reduce graft events and thrombosis in patients with saphenous vein graft disease has complet…
-
CLINICAL_TRIALS trial_result · 2018-08-09Clinical Trial Update: Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial) [Phase 3]
Phase 3 trial update on aggressive cholesterol therapy to reduce vein graft events after CABG; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts [NA]
This document reports the completion of the Symbiot III trial, a prospective randomized study evaluating the Symbiot covered stent system in…
-
CLINICAL_TRIALS trial_result · 2007-03-14Clinical Trial Update: RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent. [Phase 2]
A Phase 2 clinical trial (RRISC) evaluating the Cypher sirolimus-eluting stent to reduce restenosis in saphenous vein grafts has completed.